When a drug is in shortage, as semaglutide has been for some time, the law allows state-licensed compounding pharmacies to create versions of that drug to meet patient needs
The GLP-1 receptor agonists used clinically are based on exendin-4 and native GLP-1 and are available as formulations for daily or weekly s.c
Retatrutide (LY3437943) is a novel triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously
Available from: Asghar F, Shamim N, Farooque U, Sheikh H, Aqeel R
Each of our carefully formulated and cutting edge formulations target your bloodstream directly, meaning that we are able to aid in the treatment of a variety of conditions, as well as providing a veritable buffet of cosmetic, fitness and wellness solutions.